Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT05632978

An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data

An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data — Recruiting • Neurology • NCT05632978.

📅 23 Oct 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT05632978
Start
2023-04-24
Completion
2032-12
ClinicaliQ Trial Snapshot
  • An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data — Recruiting • Neurology • NCT05632978.
  • Study collecting blood samples and routine clinical data from people with epilepsy to identify patterns in causes, genetics, and brain characteristics.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The goal of this observational study is to learn more about phenotypic, genetic, biochemical, neurophysiological and radiological patterns in epilepsy. Participants will be asked to consent to use of clinical and paraclinical data (obtained during standard care) for research, and will be asked to donate blood samples at their routine clinic visits. Conditions: Epilepsy Lead Sponsor: Cardiff and Vale University Health Board Planned Enrollment: 2000 participants

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Smart beds and motion sensors – is this the future of dementia care?
Neurology · BBC Health · 20 Sep 2026
Key takeaways for clinical practice: Smart home technology including motion sensors, bed monitors, and wearable devices (socks) can enable remote monitoring of…
View brief →
Clinical Brief
Student quits university due to epilepsy medicine shortages
Neurology · BBC Health · 03 Aug 2026
Epilepsy medication shortages are affecting patient access – Supply issues are severe enough to impact students' ability to continue their education, highlighting…
View brief →
Clinical Brief
Nobel Prize awarded for revealing inner workings of the brain
Neurology · BBC Health · 05 Oct 2026
Karl Deisseroth, Peter Hegemann, and Georg Nagel have been awarded the Nobel Prize for developing optogenetics, a technique enabling precise control of…
View brief →
Guideline
Software with artificial intelligence (AI)-derived algorithms to help interpret electroencephalograms (EEGs) for suspected epilepsy: early-use assessment
Neurology · 01 Oct 2026
AI-assisted EEG interpretation software can support clinicians in identifying abnormalities suggestive of epilepsy, but should complement rather than replace expert clinical review—use…
View guideline →
Clinical Brief
AI may speed up search for drugs to treat brain conditions
Neurology · BBC Health · 22 May 2026
AI tools are being developed to accelerate drug discovery for neurological conditions including motor neurone disease, potentially reducing development timelines This approach…
View brief →
Guideline
2022 EAN Guidelines on Epilepsy Management in Adults
Neurology · 30 Mar 2026
This EAN guideline addresses 2022 EAN Guidelines on Epilepsy Management in Adults in Neurology. Use it to review current recommendation wording, eligibility…
View guideline →